Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase

Abstract

The Rho activator ECT2 functions as a key regulator in cytokinesis. ECT2 is phosphorylated during G2/M phase, but the physiological significance of this event is not well known. In this study, we show that phosphorylation of ECT2 at threonine-341 (T341) affects the autoregulatory mechanism of ECT2. In G2/M phase, ECT2 was phosphorylated at T341 most likely by Cyclin B/Cyclin-dependent kinase 1 (Cdk1), and then dephosphorylated before cytokinesis. Depletion of ECT2 by RNA interference (RNAi) efficiently induced multinucleate cells. Expression of the phospho-deficient mutant of ECT2 at T341 suppressed the multinucleation induced by RNAi to ECT2, indicating that ECT2 is biologically active even when it is not phosphorylated at T341. However, the phospho-mimic mutation at T341 weakly stimulates the catalytic activity of ECT2 as detected by serum response element reporter gene assays. As T341 is located at the hinge region of the N-terminal regulatory domain and C-terminal catalytic domain, phosphorylation of T341 may help accessing downstream signaling molecules to further activate ECT2. We found that the phospho-mimic mutation T341D increases binding with itself or the N-terminal half of ECT2. These results suggest a conformational change of ECT2 upon phosphorylation at T341. Therefore, ECT2 activity might be regulated by the phosphorylation status of T341. We propose that T341 phosphorylation by Cyclin B/Cdk1 could be a trigger for further activation of ECT2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 9
Figure 4
Figure 5
Figure 7
Figure 6
Figure 8

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Echard A, O'Farrell PH . (2003). Curr Biol 13: 373–383.

  • Elia AE, Cantley LC, Yaffe MB . (2003). Science 299: 1228–1231.

  • Hill CS, Wynne J, Treisman R . (1995). Cell 81: 1159–1170.

  • Hirose K, Kawashima T, Iwamoto I, Nosaka T, Kitamura T . (2001). J Biol Chem 276: 5821–5828.

  • James P, Halladay J, Craig EA . (1996). Genetics 144: 1425–1436.

  • Kim JE, Billadeau DD, Chen J . (2005). J Biol Chem 280: 5733–5739.

  • Kimura K, Tsuji T, Takada Y, Miki T, Narumiya S . (2000). J Biol Chem 275: 17233–17236.

  • Lee KS, Erikson RL . (1997). Mol Cell Biol 17: 3408–3417.

  • Liu XF, Ishida H, Raziuddin R, Miki T . (2004). Mol Cell Biol 24: 6665–6675.

  • Lorenzi MV, Castagnino P, Chen Q, Hori Y, Miki T . (1999). Oncogene 18: 4742–4755.

  • Lowery DW, Mohammad DH, Elia AE, Yaffe MB . (2004). Cell Cycle 3: 128–131.

  • Matuliene J, Kuriyama R . (2004). Mol Biol Cell 15: 3083–3094.

  • Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N et al. (1997). Eur J Biochem 243: 527–536.

  • Miki T, Smith C, Long J, Eva A, Fleming T . (1993). Nature 362: 462–465.

  • Mishima M, Pavicic V, Gruneberg U, Nigg EA, Glotzer M . (2004). Nature 430: 908–913.

  • O'Keefe L, Somers WG, Harley A, Saint R . (2001). Cell Struct Funct 26: 619–626.

  • Obaya AJ, Sedivy JM . (2002). Cell Mol Life Sci 59: 126–142.

  • Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I et al. (2004). J Biol Chem 279: 7169–7179.

  • Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H et al. (2003). J Cell Biochem 90: 819–836.

  • Sakata H, Rubin JS, Taylor WG, Miki T . (2000). Hepatology 32: 193–199.

  • Shah OJ, Ghosh S, Hunter T . (2003). J Biol Chem 278: 16433–16442.

  • Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T . (1999). J Cell Biol 147: 921–927.

  • Thiel DA, Reeder MK, Pfaff A, Coleman TR, Sells MA, Chernoff J . (2002). Curr Biol 12: 1227–1232.

  • Ubersax JA, Woodbury EL, Quang PN, Paraz M, Blethrow JD, Shah K et al. (2003). Nature 425: 859–864.

  • Wheatley SP, Hinchcliffe EH, Glotzer M, Hyman AA, Sluder G, Wang Y . (1997). J Cell Biol 138: 385–393.

  • Yoshizaki H, Ohba Y, Parrini MC, Dulyaninova NG, Bresnick AR, Mochizuki N et al. (2004). J Biol Chem 279: 44756–44762.

Download references

Acknowledgements

This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute Center for Cancer Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Miki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hara, T., Abe, M., Inoue, H. et al. Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene 25, 566–578 (2006). https://doi.org/10.1038/sj.onc.1209078

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209078

Keywords

This article is cited by

Search

Quick links